The elevation of such dicarbonyl compounds as glyoxal and the depletion of GSH occur simultaneously in diabetic patients. Enabling a nonenzymatic glycation reaction with GSH and glyoxal is therefore proposed. However, the reaction mechanism for GSH and glyoxal has not been precisely defined. We isolated in this study the major products obtained by the reaction of GSH and glyoxal under physiological conditions, and clarified the chemical structure of these compounds by MS and NMR analyses for the first time. We identified the major product after 24 h as N-[3-(2,5-dioxomorpholin-3-yl)-propanoyl]cysteinylglycine, and the one after 30 min as N-glycoloyl--glutamylcysteinylglycine (the intermediate of the former compound). Our results suggest that GSH reacted with glyoxal at the -NH 2 group of the glutamate residue, but not at the SH group of the cysteine residue.
GSH is the major low-molecular-mass thiol compound in plants and animals. It is typically present in high concentrations (0.1-10 mM) in the cytosol, 1) protects cells from the toxic effects of reactive oxygen species and maintains a cellular redox status. 2) In addition, GSH is also involved in the metabolism of foreign objects.
A chemical reaction between carbohydrates and proteins (nonenzymatic glycation) frequently occurs in the plasma. This reaction is accelerated in the state of hyperglycemia in diabetes, and advanced glycation end-products (AGEs) are produced through this reaction. AGEs have been reported to be correlated with the progression of diabetes and aging. 3) In addition to carbohydrates, highly reactive -dicarbonyl compounds have also been shown to react with proteins and initiate the formation of AGEs. 4) Among the -dicarbonyl compounds, glyoxal, which is formed by the degradation of glycated proteins, oxidative degradation of glucose, lipid peroxidation, and ascorbate autoxidation, 5, 6) has been proposed to be one of the main reactants for AGEs. Elevation of the glyoxal concentration in the plasma of diabetic and uremic patients has also been reported. 7, 8) A reaction concerning the nonenzymatic glycation of GSH has recently been observed. Januel et al. have reported that ribose formed Amadori compounds with the -NH 2 group of the glutamate residue in GSH, and that these Amadori compounds inhibited glutathione peroxidase.
9) Linetsky et al. have shown that the reaction of GSH with glucose (or fructose) at the -NH 2 group of the glutamate residue in GSH resulted in the formation of Amadori (or Heynes) compounds, and that the products inhibited several glutathionerelated enzymes. 10, 11) Since these enzymes contribute to the cell defence system against toxic reactive species, 12, 13) glycation of GSH may lead to diabetic complications.
Since the elevation of glyoxal and depletion of GSH in the plasma of diabetic patients have been reported, 7, 8, 14) we hypothesized that glyoxal may be a reactive molecule for GSH and investigated the reaction between glyoxal and GSH. In this present study, we isolated the major products produced by the reaction with GSH and glyoxal under physiological conditions by preparative HPLC, and determined their structures by MS and NMR. A novel and specific reaction mechanism between GSH and glyoxal is reported here.
Materials and Methods
Materials. GSH was purchased from Wako Pure Chemical Industries (Osaka, Japan). A 40% aqueous glyoxal solution and the other reagents were purchased from Kanto Kagaku (Tokyo, Japan).
Incubation of GSH with glyoxal. GSH (10 mM) was incubated with glyoxal (10 mM) in a 100 mM sodium phosphate buffer (pH 7. Isolation of the GSH-glyoxal reaction product. 307 mg (1 mmol) of GSH in 100 ml of a sodium phosphate buffer (100 mM, pH 7.4) was incubated with glyoxal (1 mmol) at 37 C for 30 min or 24 h. After filtration being passed through a 0.20-mm filter (Advantec, Japan), the reaction mixture was concentrated to dryness under reduced pressure. The concentrate was extracted with 10 ml of a dichloromethanemethanol-water (3:1:0.2) solution, and the supernatant was evaporated to dryness. This extract was dissolved in 2 ml of 50 mM hydrochloric acid, and each 40 ml of the solution was purified by preparative HPLC under the following conditions: column, Inertsil ODS-3 (10 mm i.d. Â 250 mm, GL Sciences, Japan); solvent, 0.1% trifluoroacetic acid y To whom correspondence should be addressed. Tel/Fax: +81-3-5981-3433; E-mail: kshindo@fc.jwu.ac.jp Abbreviations: AGE, advanced glycation end-product; HRESI-MS, high resolution electrospray ionization mass spectrometry in water (solvent A); 0.1% trifluoroacetic acid in acetonitrile (solvent B); linear gradient of B 2-15% in 30 min; flow rate, 5 ml/min; detection, 230 nm; temperature, 40 C. The peaks at retention times of 9.6 min (30-min reaction solution) and 14.5 min (24-h reaction solution) were collected and lyophilized to give 12.8 mg (compound 1, 5.8% yield) and 50.6 mg (compound 2, 25% yield) of pure materials.
Structural analysis. High-resolution electrospray ionization mass spectrometry (HRESI-MS) was recorded with a Jeol JMS-T100LP. 1 H-and 13 C-NMR spectra were measured with a Bruker AMX400. Chemical shifts are given in ppm, using DSS as an external standard. 
Results and Discussion
To clarify the reaction mechanism for GSH with glyoxal, the reaction products of GSH with or without glyoxal under physiological conditions (pH 7.4, 37
C, up to 24 h) were investigated by a diode array detection-HPLC analysis. The results are shown in Fig. 1 . In a control sample (without glyoxal), approximately 30% of GSH changed to GSSG within 24 h, while a rapid timedependent decrease in GSH and the formation of new reaction products were observed in an experimental sample. After 24 h of incubation, about 60% of GSH was converted to reaction products. In the HPLC analysis, two main peaks (retention times of 11.4 min and 14.8 min) were observed. The peak at retention time 11.4 min (compound 1) appeared after 5 min, reached a maximum after 30 min, and disappeared after 2 h, while the peak at retention time 14.8 min (compound 2) appeared after 1 h and reached a maximum after 24 h (Fig. 1 ). These observations indicated that these two compounds could be related to each other. To confirm this, each compound was purified by the procedure described in the Materials and Methods section, enabling 12.8 mg of pure 1 and 50.6 mg of pure 2 to be obtained. The structural analysis was started with 2 because it was more stable than 1 in a D 2 O solution.
The molecular formula for 2 was determined as
by HRESI-MS, corresponding to the addition of one molecule of glyoxal to GSH and the loss of one molecule of water.
The 1 H-NMR, 13 C-NMR, 1 H-1 H COSY, and HMQC spectra of 2 in D 2 O were measured and compared with those of GSH. The comparison proved that all the 1 H and 13 C signals in GSH (derived from glutamate, cysteine, and glycine) were present in 2. Signals of one carbonyl carbon ( 172.9, C-7 00 ) and one isolated methylene ( 48.3, C-6 00 ) were observed only in 2. An HMBC experiment on 2 proved the 1 H-13 C long-range coupling from H-6 00 ( 3.94 and 4.28, isolated methylene) to C-5 00 ( 182.6) and C-7 00 , and from H-3 00 ( 2.45, -methylene of Glu) to C-5 00 . Considering the molecular formula of 2, the presence of a 2, 5-dioxomorpholine structure containing C-4 00 , C-5 00 , C-6 00 , and C-7 00 in 2 was thus proposed. C-7 00 and C-5
00
were assigned to an amide carbonyl and ester carbonyl, respectively, by the observation of deuterium-induced upfield shifts at C-4 00 and C-7 00 in the 13 C-NMR spectrum of 2 taken in D 2 O/H 2 O (no upfield shifts were observed at C-5 00 or C-6 00 ). 15) All of these observations allowed the structure of 2 to be determined as shown in Fig. 2 . Thus, compound 2 was identified as N-[3-(2,5-dioxomorpholin-3-yl)propanoyl]-cysteinylglycine and was considered to be a novel compound according to the CAS database. The 1 H-and 13 C-NMR data for compound 2 are summarized in Table 1 .
The molecular formula of 1 was determined to be
by HRESI-MS data. Since 1 was unstable in D 2 O, the structure of 1 was analysed by a comparison of the 1 H-NMR spectrum of 1 with that of 2. In the comparison, all the 1 H signals derived from glutamate, cysteine, and glycine in 2 were conserved in 1. Signals of an isolated methylene (H-6 00 ) of 1 were observed as a singlet and in a higher field ( 3.96) compared to the corresponding signals of 2 ( 3.94 (d, J ¼ 16:5 Hz) and 4.28 (d, J ¼ 16:5 Hz)). These findings enabled the structure of 1 to be determined as N-glycoloyl--glutamylcysteinylglycine which is a novel compound according to the CAS database. The 1 H-NMR data for compound 1 are summarized in Table 1 .
The formation of 1 and 2 can be explained according to the reaction scheme shown in Fig. 3 . The addition of glyoxal to the N-terminal amino group of GSH may have led to keto-enol tautomerism, and 1 may have been produced. The subsquent dehydrating condensation between the remaining hydroxyl group and carboxyl group of the GSH glutamyl moiety (the formation of a lactone) may have resulted in the formation of a dioxomorpholine derivative (2) .
N-terminal modification of GSH induced by glyoxal was clarified for the first time in this study. In a previous study, Zeng and Davies detected a molecular ion peak ðM þ HÞ þ at m=z 348 from an ESI-MS analysis of the incubated mixtures of N-acetyl-cysteine, GSH and glyoxal, suggesting the formation of a reaction product between glyoxal and GSH. 16) However, the chemical structure of this peak was not determined by them. Since the molecular weight of 2 was 347, it is possible that their ion peak was identical to 2.
Krause et al. have demonstrated that N-terminal modification of the model peptide, Gly-Ala-Phe, induced by glyoxal under physiological conditions resulted in the formation of a pyrazinone-type structure possessing a characteristic UV absorption maximum at 322 nm. 17) Chuyen et al. also reported the same reaction between the tripeptide, Leu-Gly-Gly, and glyoxal under food processing conditions. 18) However, such a characteristic UV absorption compound was not found in the present study. The difference in the reaction was due to the -glutamyl residue in GSH. Therefore, a dioxomorpholine-type product like compound 2 would probably be a specific product when glyoxal reacts with GSH.
Linetsky et al. have reported that the reaction products of glucose (or fructose) and GSH [Amadori (or Heynes) compounds] did not work efficiently as the substrate of glutathione peroxidase and glutathione S-transferase because of the loss of the NH 2 group in GSH which was utilized to form hydrogen bonds between GSH and the enzyme.
10,11) Since 1 and 2 had also lost the NH 2 group, these compounds may not work as substrates for the foregoing enzymes.
In conclusion, this study has clarified the reaction mechanism between GSH and glyoxal for the first time. Before this study, we thought that the SH group of the cysteine residue in GSH may have been the primary reaction target for glyoxal; however, the corresponding reaction products were not obtained, suggesting that the reaction of N-terminal modification occurred favorably in the reaction between GSH and glyoxal. Although the physiological roles of 1 and 2 have not yet been tested, the depletion of GSH in cytosol could at least contribute to an increase in oxidative stress. 
